Tenor Capital Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Tenor Capital Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-150,000	Closed	-$3.25K	–	378
2023 Q3	$3.25K	Hold	150,000	–	–	﹤0.01%	319
2023 Q2	$4.07K	Hold	150,000	–	–	﹤0.01%	343
2023 Q1	$6.46K	Hold	150,000	–	–	﹤0.01%	388
2022 Q4	$7.16K	Hold	150,000	–	–	﹤0.01%	454
2022 Q3	$9K	Hold	150,000	–	–	﹤0.01%	603
2022 Q2	$21K	Buy	+150,000	New	+$24.6K	﹤0.01%	587

Other funds holding CMRAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Tenor Capital Management's CMRAW Position: Q4 2023 in Review

Tenor Capital Management sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 150,000 shares — an estimated $3.25K sold.

Tenor Capital Management first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $21K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

Tenor Capital Management reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
Tenor Capital Management sold 150,000 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $3.25K.
Tenor Capital Management first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
Tenor Capital Management's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $21K in Q2 2022.
3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Tenor Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.